AZD8055 on Regulatory T cell Manufacturing for Clinical Use in Transplantation

Grants and Contracts Details

StatusFinished
Effective start/end date2/6/21 → 1/31/23

Funding

  • AstraZeneca Pharmaceuticals AB: $79,676.00